Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility
about
Structural and functional characterization of endothelial microparticles released by cigarette smoke.Extracellular Vesicles in Chronic Obstructive Pulmonary DiseaseEndothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease studyPulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD StudyThe association of systemic microvascular changes with lung function and lung density: a cross-sectional studyA phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.Pulmonary Extracellular Vesicles as Mediators of Local and Systemic Inflammation.Circulating endothelial microparticles involved in lung function decline in a rat exposed in cigarette smoke maybe from apoptotic pulmonary capillary endothelial cellsProduction, fate and pathogenicity of plasma microparticles in murine cerebral malaria.Assessments of endothelial function and arterial stiffness are reproducible in patients with COPD.Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysemaAcute exacerbation of COPD: is it the "stroke of the lungs"?Sirt1 expression is associated with CD31 expression in blood cells from patients with chronic obstructive pulmonary disease.Annual FEV1 changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective studyThe role of microparticles in chronic obstructive pulmonary diseaseLymphocyte-derived microparticles induce apoptosis of airway epithelial cells through activation of p38 MAPK and production of arachidonic acid.Rapid shedding of proinflammatory microparticles by human mononuclear cells exposed to cigarette smoke is dependent on Ca2+ mobilization.The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD).Microparticles in sputum of COPD patients: a potential biomarker of the disease?Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity.The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients.Extracellular Vesicle Biology in the Pathogenesis of Lung Disease.Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro.Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding.Chronic obstructive pulmonary disease: a disease of the endothelium?Increased circulating platelet microparticles as a potential biomarker in asthma.Disturbed blood flow worsens endothelial dysfunction in moderate-severe chronic obstructive pulmonary disease.Extracellular Vesicle MicroRNA Transfer in Lung Diseases.Microparticles as biomarkers of lung disease: enumeration in biological fluids using lipid bilayer microspheres.Effects of Cigarette Smoke on Pulmonary Endothelial Cells.Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.Chronic obstructive pulmonary disease: MicroRNAs and exosomes as new diagnostic and therapeutic biomarkers.Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease.Extracellular Vesicle: An Emerging Mediator of Intercellular Crosstalk in Lung Inflammation and Injury.Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmornary Disease? What Do We Need to Add?Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers.Lungs, Bone Marrow, and Adipose Tissue. A Network Approach to the Pathobiology of Chronic Obstructive Pulmonary Disease
P2860
Q27317115-93B73160-A6EA-4517-8641-E511DF7898DAQ28078352-4352BB1F-B3B4-449B-B5BF-DDA878FDF236Q28386977-B20FFAFD-3E80-4C92-9142-BC45ED51B813Q28390489-E31A51EA-EBDF-4113-B9D5-1A6758904467Q28392241-BEDC42A5-7A95-4C3F-AC22-80DC221D43D2Q30763711-37AE3614-054D-49C5-B07A-B61809205935Q33603530-77993AF2-253B-4978-959B-69B308ED30D4Q33814681-885C9FFC-82C1-4F3B-80D2-F8169BE595E6Q35126111-024C83ED-FCE7-47D9-895E-76897C578ECBQ36079394-CBD798D5-B93B-4986-92BC-7DC00C0BCE15Q36307560-79E079E3-D8EB-4E7E-94F3-7FBEE78E5F9EQ37103385-8CB6B73C-1460-4485-8E8F-7A976284F0C9Q37370002-84920D79-723B-4A11-A71F-2ABC86702C81Q37628496-4DC65E52-000C-40B4-8E59-76286918AA54Q38202635-22234ED9-F2E8-46AE-BE65-177E01F338DCQ39000615-C2D3C3AB-7C34-4C65-BD6A-61F1A56A91C4Q39018282-1C4EEE99-A0DF-4F82-BC93-69B0AF5EA5FDQ39094033-6EF99BD8-4F77-469F-8B31-FF59B0082390Q39167010-F7415ECC-B1E6-4CDD-9D88-F215A7B82219Q39413926-C663E886-9AB8-434F-AFD5-17051C2DBD62Q39426025-744CAABA-BCBA-4A23-9014-487E2D9FD89AQ40134679-49DC539D-4289-48E6-831D-BF9BB75E1E15Q42268357-63A457E6-7FD1-434C-BD58-AC37EE25D12CQ42474294-4E74D7FB-2F6A-445C-A32C-211ED25FDF1BQ46329191-E1DCE6C5-1374-4F3E-AABA-AC4964B96617Q46477681-4AE2779F-5DDA-4C50-96D2-D21D36B369CDQ47140506-60EA878C-492F-490A-8898-4A4303E8CC0CQ47219580-6133EE5B-6892-49C9-8EB7-787A88D738D6Q47582677-E9DAB014-5245-4BC4-B5DD-887289D7F317Q47652532-6B3C8C30-B03C-4ED9-8205-FA6A495CC180Q47964479-61325D93-B62A-45A2-92CF-5DB1BC1DE88BQ52564605-5E2E5A33-1625-45ED-906F-B654CB3083A1Q53822322-9686640D-C440-4FA4-820F-49E43A911A3EQ55184606-F74D46CA-3BF0-4F95-AF09-C44853CD9DDFQ55415106-F54D41C9-48CD-4ACA-94E9-8D64D36EC70DQ55461485-78525223-BB67-4866-884D-4EEADEBBC3D6Q58840414-DBC3927F-7964-4222-83C0-8ADE6FD819A2
P2860
Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility
description
im Juli 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 27 July 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2012
@uk
name
Increased circulating endothel ...... PD exacerbation susceptibility
@en
Increased circulating endothel ...... PD exacerbation susceptibility
@nl
type
label
Increased circulating endothel ...... PD exacerbation susceptibility
@en
Increased circulating endothel ...... PD exacerbation susceptibility
@nl
prefLabel
Increased circulating endothel ...... PD exacerbation susceptibility
@en
Increased circulating endothel ...... PD exacerbation susceptibility
@nl
P2093
P50
P921
P1433
P1476
Increased circulating endothel ...... PD exacerbation susceptibility
@en
P2093
Chiharu Ota
Masaru Yanai
Mutsuo Yamaya
Satoshi Suzuki
Seiichi Kobayashi
Shin Kurosawa
Takaya Suzuki
Toru Takahashi
P304
P356
10.1136/THORAXJNL-2011-201395
P407
P577
2012-07-27T00:00:00Z